JAZZ PHA reported $-263386000 in EBIT for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
ALKERMES ALKS:US USD -19227000 41.41M
Amarin AMRN:US USD 1.43M 39.05M
Cara Therapeutics CARA:US USD -31307000 7.46M
Coherus Biosciences CHRS:US USD -51493000 28.96M
Eli Lilly And LLY:US USD 2.11B 169.2M
Emergent Biosolutions EBS:US USD -58400000 16.4M
Endo International Ordinary Shares ENDP:US USD 55.64M 26.07M
Halozyme Therapeutics HALO:US USD 75.91M 7.78M
Heron Therapeutics HRTX:US USD -41882000 7.62M
Hikma Pharmaceutical HIK:LN USD 302M 46M
Horizon Pharma HZNP:US USD 214.96M 26.8M
Mckesson MCK:US USD 1.25B 118M
Merk MRK:US USD 4.81B 725M
Nektar Therapeutics NKTR:US USD -40889000 3.42M
Pacira Pharmaceuticals PCRX:US USD 14.24M 7.54M
Perrigo Ordinary Shares PRGO:US USD 41.3M 10.9M
Pfizer PFE:US USD 5.81B 3.89B
Phibro Animal Health PAHC:US USD 22.41M 8.73M
Revance Therapeutics RVNC:US USD -74622000 2.86M
Supernus Pharmaceuticals SUPN:US USD 34.33M 35.86M
Teva Pharmaceutical Industries TEVA:US USD 999M 259M
Xeris Pharmaceuticals Inc XERS:US USD -15170000 3.51M
Zoetis ZTS:US USD 698M 27M